Pharmafile Logo
Pharmafocus logo
Advanced Search

NICE approves Roche’s Gazyvaro and Novartis’ Xolair

March 11, 2015
Research and Development, Sales and Marketing Gazyvaro, NICE, Novartis, Roche, Xolair, obinutuzumab, omalizumab

NICE today gave the green light to three new biological drugs, after recommending Roche’s Gazyvaro, GSK’s Arzerra and Novartis’ Xolair …

News
tom_griffiths_virgo

New head of digital for Virgo Health

March 11, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Virgo HEALTH, tom griffiths

UK-based healthcare comms agency Virgo Health has increased its leadership team through the appointment of Tom Griffiths as head of digital.  …

Appointment

HRT pills linked to increase in clots and strokes

March 10, 2015
Research and Development, Sales and Marketing Cochrane, HRT, boardman, hormone replacement therapy

HRT tablets do not offer heart benefits and slightly increase the risk of strokes and blood clots in some women. …

News
Lilly image

German court rules against Lilly in Alimta patent case

March 10, 2015
Manufacturing and Production, Sales and Marketing ACS, Actavis, Alimta, NICE, NSCLC, lilly, lung cancer, pemetrexed

A German court has ruled that Lilly’s patent for its lung cancer drug Alimta would not be infringed by generic …

News
Sovaldi image

$10 generic Solvaldi emerges in Bangladesh

March 10, 2015
Manufacturing and Production, Sales and Marketing Gilead, World Trade Organization, hep C, incepta, sofosbuvir, sofosbuvir), sovaldi

A Bangladeshi pharma company is producing an unlicensed generic version of Gilead’s hepatitis C drug Sovaldi for $10 per pill …

News
Champix image

FDA gives new safety warning on Pfizer’s Champix

March 10, 2015
Manufacturing and Production, Sales and Marketing Champix, Cochrane, FDA, MHRA, Pfizer, varenicline

The FDA has warned that Pfizer’s stop smoking drug Champix is linked with seizures, aggressive behaviour and blackouts. In its …

News
Apple’s senior VP of operations Jeff Williams presented ResearchKit at the watch

Apple highlights ‘ResearchKit’ through watch launch

March 10, 2015
Medical Communications, Sales and Marketing Apple, FDA, digital, health, healthkit, researchkit, wearables

US tech giant Apple has finally launched its digital wearable device along with a ResearchKit platform that allows apps to …

News
Sanofi image

Oncologists say CDF cuts will compromise treatment

March 10, 2015
Sales and Marketing CDF, Jevtana, NHS, NICE, Sanofi, cabazitaxel, doctors.net, m3

Oncologists believe cutting drugs from the Cancer Drugs Fund won’t save the NHS money and will worsen patient outcomes according …

News
robert_castaigne_sanofi

Sanofi names audit committee chairman

March 10, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Robert Castaigne, Sanofi

Sanofi has looked to its own board to fulfil the role of chairman as it names Robert Castaigne chairman of …

Appointment
Targcept image

Targacept and Catalyst sign $100 million deal

March 9, 2015
Research and Development, Sales and Marketing CB 813d, PF-05280602, Targecept, blood disorder, catalyst biosciences

Targacept and Catalyst Biosciences have signed a merger agreement which will see them develop new treatment options for patients with …

News
Saxenda image

Novo Nordisk obesity drug shows added benefits

March 9, 2015
Sales and Marketing (liraglutide), Contrave, Novo Nordisk, Victoza, Xenical, liraglutide, obesity, saxenda, weight

New research by Novo Nordisk has suggested that its obesity drug Saxenda can help improve several other weight-related problems as …

News

FDA approves new anti-fungal treatment

March 9, 2015
Sales and Marketing Astellas, Basilea, FDA, US, cresemba, isavuconazonium sulfate, zygomycosis

The FDA has given the OK to Astellas and Basilea for their new treatment in adults with a rare but …

News
Cancer image

Fixing what’s broken: why companies must prioritise innovation in drug development

March 9, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, ICR, The Institute of Cancer Research, innovation, oncology, paul workman

The global system for discovering new cancer drugs is broken. It is failing to turn dramatic scientific advances into enough …

Feature
franklin_berger

ESSA Pharma appoints independent director

March 9, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing essa pharma, franklin berger

US pharma development firm ESSA Pharma has appointed Franklin Berger as an independent director. A resident of New York, Berger’s …

Appointment
Merck image

Merck and NewLink Ebola vaccine trial begins

March 6, 2015
Sales and Marketing Ebola, Merck, Vaccine, WHO, newlink, rVSV-EBOV

Merck and US-based biopharma firm NewLink Genetics’ investigational Ebola vaccine is being used in Phase III trials in West Africa. …

News
Novartis image

Novartis secures first US biosimilar product

March 6, 2015
Research and Development, Sales and Marketing Amgen, Cancer, FDA, Neupogen, Novartis, Sandoz, Zarxio, biosimilar, filgrastim-sndz

Novartis’ generic arm Sandoz has won the race to become the first company to market a biosimilar in the US …

News
Keytruda image

Merck and Eisai partner on cancer therapy trial

March 6, 2015
Research and Development, Sales and Marketing Bayer, Cancer, FDA, Halaven, Lenvima, Merck, Stivarga, keytruda, oncology, pd1

Merck and Eisai are teaming up for collaborative trials to test the effects of using combinations of each company’s oncology …

News

FDA launches drug shortages app

March 6, 2015
Medical Communications, Sales and Marketing Apple, FDA, app, drug, google, play, recall, shortages

The US Food and Drug Administration has launched its first smartphone app which provides valuable information about drug shortages. The …

News
Eliquis image

Anti-blood clotting drug Eliquis gets NICE nod

March 6, 2015
Sales and Marketing BMS, DVT, Eliquis, NICE, Pfizer, Pradaxa, apixaban, clotting

Bristol-Myers Squibb and Pfizer’s Eliquis for preventing blood clots has been shown the green light to treat venous thromboembolism (VTE), …

News
scott_byrd

Acacia Pharma appoints two directors to board

March 6, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing acacia pharma, christine soden, scott byrd

UK pharma firm Acacia Pharma that develops drugs for supportive care has confirmed Scott Byrd and Christine Soden have joined …

Appointment
The Gateway to Local Adoption Series

Latest content

Sandoz launches allergy relief nasal spray in Germany and Switzerland

April 9, 2026

Japan approve Daiichi Sankyo’s Enhertu as a second-line treatment for gastric cancer

April 9, 2026

Trelleborg to take part in Medtec Japan 2026

April 8, 2026

Kainova Therapeutics expands phase I/II trial of antibody drug

April 7, 2026

Eisai starts enrolment for phase 2 narcolepsy study evaluating E2086

April 7, 2026